technology
Bad cholesterol slashed 62% by single dose of gene-editing drug in small trial
arstechnica.com • 28 May 2026, 15:39
The interim Phase I trial data was only from 35 people, but results look good so far.
Les originalartikkelen
Relaterte artikler etter nøkkelord
people
- Nintendo's Pictonico! is a chaotic and unexpectedly good time
- Grifters, cynics, and true believers: The family tree of vaccine opponents
- Drug that grew extra teeth in mice enters first human trial
- The pyramids' missing casing stones have a better story than "thieves"
- An Iraqi journalist threw his shoes at George W. Bush, kicking off a copycat era